Literature DB >> 26121536

How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society.

David J Gladstone, William H Geerts, James Douketis, Noah Ivers, Jeff S Healey, Kori Leblanc.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26121536     DOI： 10.7326/M15-0143

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  8 in total

1.  Practical Guide to Direct New Oral Anticoagulant Use for Secondary Stroke Prevention in Atrial Fibrillation.

Authors:  Rochelle Sweis; José Biller
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-04

2.  A pharmacist checklist for direct oral anticoagulant management: Raising the bar.

Authors:  Kori Leblanc; William M Semchuk; John Papastergiou; Blair Snow; Leilany Mandlsohn; Vinay Kapoor; Lisa M Guirguis; James D Douketis; William Geerts; David J Gladstone
Journal:  Can Pharm J (Ott)       Date:  2018-02-09

3.  Preventability of serious thromboembolic and bleeding events related to the use of oral anticoagulants: a prospective study.

Authors:  Anne-Laure Sennesael; Anne-Sophie Larock; Bérangère Devalet; Valérie Mathieux; Franck Verschuren; Xavier Muschart; Olivia Dalleur; Jean-Michel Dogné; Anne Spinewine
Journal:  Br J Clin Pharmacol       Date:  2018-04-17       Impact factor: 4.335

4.  Direct oral anticoagulant use and the incidence of bleeding in the very elderly with atrial fibrillation.

Authors:  Fatima Khan; Hans Huang; Yvonne H Datta
Journal:  J Thromb Thrombolysis       Date:  2016-11       Impact factor: 2.300

5.  Implications of Recent Drug Approvals for Older Adults.

Authors:  Christine Eisenhower; Michael Koronkowski; Zachary Marcum
Journal:  Ann Longterm Care       Date:  2016-01-14

6.  Assessment of a Pharmacist-Led Direct Oral Anticoagulant Monitoring Clinic.

Authors:  Jenna Haché; Kwadwo Osei Bonsu; Rufaro Chitsike; Hai Nguyen; Stephanie Young
Journal:  Can J Hosp Pharm       Date:  2021-01-01

Review 7.  Management of antithrombotic therapy during cardiac implantable device surgery.

Authors:  Ahmed AlTurki; Riccardo Proietti; David H Birnie; Vidal Essebag
Journal:  J Arrhythm       Date:  2016-01-18

8.  Factors That Determine the Prothrombin Time in Patients With Atrial Fibrillation Receiving Rivaroxaban.

Authors:  Jen-Hung Huang; Yung-Kuo Lin; Cheng-Chih Chung; Ming-Hsiung Hsieh; Wan-Chun Chiu; Yi-Jen Chen
Journal:  Clin Appl Thromb Hemost       Date:  2018-09-24       Impact factor: 2.389
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.